Found: 4
Select item for more details and to access through your institution.
Impact of hematologic malignancy and type of cancer therapy on COVID-19 severity and mortality: lessons from a large population-based registry study.
- Published in:
- Journal of Hematology & Oncology, 2020, v. 13, n. 1, p. N.PAG, doi. 10.1186/s13045-020-00970-7
- By:
- Publication type:
- Article
Safety of intra-cerebrospinal fluid chemotherapy in onco-haematological patients: a retrospective analysis of 627 interventions.
- Published in:
- Journal of Neuro-Oncology, 2015, v. 125, n. 2, p. 351, doi. 10.1007/s11060-015-1922-y
- By:
- Publication type:
- Article
Real-World Outcomes of Belantamab Mafodotin for Relapsed/Refractory Multiple Myeloma (RRMM): Preliminary Results of a Spanish Expanded Access Program (EAP).
- Published in:
- Oncology & Therapy, 2023, v. 11, n. 1, p. 83, doi. 10.1007/s40487-022-00212-5
- By:
- Publication type:
- Article
Clinical outcomes after CPX‐351 in patients with high‐risk acute myeloid leukemia: A comparison with a matched cohort from the Spanish PETHEMA registry.
- Published in:
- Cancer Medicine, 2023, v. 12, n. 14, p. 14892, doi. 10.1002/cam4.6120
- By:
- Publication type:
- Article